Daniel Levy
Pediatrics · Owings Mills, MDNPI 1124010632
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $661 and has fallen 81.3% since, to $124 in 2025. Among pediatrics clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 105 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$293
- Tris Pharma Inc$269
- Ironshore Pharmaceuticals Inc.$207
- Pfizer$194
- Supernus Pharmaceuticals, Inc.$183
- Takeda Pharmaceuticals U.S.A., Inc.$161
- plus $948 from 18 others
What the payments were for
- Food & beverage$2,255100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 13 | $293 |
| Tris Pharma Inc | 12 | $269 |
| Ironshore Pharmaceuticals Inc. | 9 | $207 |
| Pfizer | 11 | $194 |
| Supernus Pharmaceuticals, Inc. | 9 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $161 |
| Neos Therapeutics, LP | 7 | $118 |
| Sanofi Pasteur Inc. | 5 | $110 |
| Merck | 5 | $108 |
| Cranial Technologies, Inc | 7 | $101 |
| Abbott | 1 | $100 |
| Cognoa, Inc. | 1 | $57 |
| Shire North American Group Inc | 2 | $48 |
| GSK | 2 | $46 |
| Kaleo, Inc. | 2 | $42 |
| AstraZeneca(2 entities) | 2 | $38 |
| Phadia US Inc. | 2 | $36 |
| Acadia Pharmaceuticals Inc | 1 | $28 |
| Alk-abello, Inc | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
| Viiv Healthcare Company | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$107
How this compares
$2,255 in reported general payments places this provider in the 90th percentile of 1,307 pediatrics providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desmopressin Acetate | 12 | $672 |
| Tamsulosin Hcl | 16 | $607 |
| Topiramate | 39 | $510 |
| Omeprazole | 12 | $347 |
| Levetiracetam | 12 | $296 |
| Atorvastatin Calcium | 18 | $225 |
| Losartan Potassium | 12 | $111 |
| Pantoprazole Sodium | 12 | $109 |
| Carvedilol | 12 | $85 |
| Lisinopril | 12 | $55 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Owings Mills
- Jitendrakumar ModiAnnapolis$149K
- Mary Elizabeth YoungerBaltimore$130K
- Hari SachsRockville$114K
- Brenda BanwellBaltimore$109K
- Ellen FieldsSilver Spring$68K
- John ThomsonBaltimore$67K
- Carmelo CuffariBaltimore$61K
- Victor AbdowRockville$58K
- John PierceRockville$47K
- Nicole RochesterSilver Spring$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.